Bright Minds Biosciences Inc.
DRUG
Peringkat dalam Saham
#13026
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics... Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatric and neurology indications; and BMB-105, a 5-HT2C agonist to treat Prader Willi Syndrome. Bright Minds Biosciences Inc. has a collaboration with Firefly Neuroscience, Inc. to provide an analysis of the electroencephalogram (EEG) data in the Company’s BREAKTHROUGH study. The company was founded in 2017 and is headquartered in New York, New York.
Harga Saham
$50.90
Kapitalisasi Pasar
$502.08M
Perubahan (1 hari)
-7.79%
Perubahan (1 tahun)
-24.48%
Negara
US
Perdagangan Bright Minds Biosciences Inc. (DRUG)
Kategori
Healthcare
Riwayat pemecahan saham untuk Bright Minds Biosciences Inc. (DRUG)
Saham Bright Minds Biosciences Inc. (simbol: DRUG) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Oct 21, 2026.
Satu lembar saham DRUG yang dibeli sebelum Oct 21, 2026 sekarang setara dengan 0 lembar saham DRUG.
Pemecahan saham terbaru terjadi pada Oct 21, 2026.
Satu lembar saham DRUG yang dibeli sebelum Oct 21, 2026 sekarang setara dengan 0 lembar saham DRUG.
Daftar pemecahan saham
| Tahun | Pemecahan | Kelipatan | Kelipatan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tanggal yang disediakan. | |||
Pemecahan saham untuk perusahaan sejenis atau pesaing
| Perusahaan | Jumlah pemecahan saham | Kelipatan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
